Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89694

1.

[Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].

Feng Q, Zhao JR, Zhang AX, Li SL.

Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):696-702. doi: 10.3760/cma.j.issn.0253-3766.2018.09.012. Chinese.

PMID:
30293397
2.

The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis.

Choi YW, Ahn MS, Jeong GS, Lee HW, Jeong SH, Kang SY, Park JS, Choi JH, Sheen SS.

Medicine (Baltimore). 2018 Sep;97(39):e12588. doi: 10.1097/MD.0000000000012588.

3.

Characteristics of overlooked synchronous gastric epithelial neoplasia after endoscopic submucosal dissection.

Nam HS, Kim HW, Choi CW, Kang DH, Park SB, Kim SJ, Choi JS.

Medicine (Baltimore). 2018 Sep;97(39):e12536. doi: 10.1097/MD.0000000000012536.

4.

A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer.

Tanaka Y, Kunisaki C, Izumisawa Y, Makino H, Kimura J, Sato S, Miyamoto H, Kosaka T, Ono HA, Takahashi M, Sato K, Akiyama H, Endo I.

Anticancer Res. 2018 Oct;38(10):6015-6021. doi: 10.21873/anticanres.12951.

PMID:
30275234
5.

Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.

Shinkai M, Imano M, Chiba Y, Hiraki Y, Kato H, Iwama M, Shiraishi O, Yasuda A, Tsubaki M, Nishida S, Kimura Y, Yasuda T.

Anticancer Res. 2018 Oct;38(10):5975-5981. doi: 10.21873/anticanres.12945.

PMID:
30275228
6.

Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.

Shinkai M, Imano M, Chiba Y, Hiraki Y, Kato H, Iwama M, Shiraisi O, Yasuda A, Tsubaki M, Nishida S, Kimura Y, Yasuda T.

Anticancer Res. 2018 Oct;38(10):5969-5974. doi: 10.21873/anticanres.12944.

PMID:
30275227
7.

Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.

Athauda A, Watkins D, Mohammed K, Chau I, Starling N, Rao S, Tait D, Aitken K, Cunningham D.

Anticancer Res. 2018 Oct;38(10):5943-5949. doi: 10.21873/anticanres.12940.

PMID:
30275223
8.

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer.

Sugiyama K, Narita Y, Mitani S, Honda K, Masuishi T, Taniguchi H, Kadowaki S, Ura T, Ando M, Tajika M, Muro K.

Anticancer Res. 2018 Oct;38(10):5859-5866. doi: 10.21873/anticanres.12928.

PMID:
30275211
9.

Roux-en-Y Plus Distal Jejunal Pouch After Total Gastrectomy: A Prospective Study.

Ishigami S, Aridome K, Arigami T, Uenosono Y, Okumura H, Kita Y, Kurahara H, Hokita S, Natsugoe S.

Anticancer Res. 2018 Oct;38(10):5837-5841. doi: 10.21873/anticanres.12925.

PMID:
30275208
10.

IL-8-251T>A (rs4073) Polymorphism Is Associated with Prognosis in Gastric Cancer Patients.

Gonzalez-Hormazabal P, Romero S, Musleh M, Bustamante M, Stambuk J, Pisano R, Lanzarini E, Chiong H, Rojas J, Castro VG, Jara L, Berger Z.

Anticancer Res. 2018 Oct;38(10):5703-5708. doi: 10.21873/anticanres.12907.

PMID:
30275190
11.

Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer.

Virgilio E, Ceci D, Cavallini M.

Anticancer Res. 2018 Oct;38(10):5581-5587. doi: 10.21873/anticanres.12892. Review.

PMID:
30275175
12.

Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.

Park R, Williamson S, Kasi A, Saeed A.

Anticancer Res. 2018 Oct;38(10):5569-5580. doi: 10.21873/anticanres.12891. Review.

PMID:
30275174
13.

Tumor microenvironmental factors have prognostic significances in advanced gastric cancer.

Ahn B, Chae YS, Kim CH, Lee Y, Lee JH, Kim JY.

APMIS. 2018 Oct;126(10):814-821. doi: 10.1111/apm.12889.

PMID:
30264431
14.

Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).

Chung CS, Tsai CL, Chu YY, Chen KC, Lin JC, Chen BC, Sun WC, Yen HH, Chen CY, Wu IC, Kuo CH, Shih HY, Bair MJ, Wang JP, Hu WH, Yang CS, Han ML, Cheng TY, Tseng CM, Tsai MC, Hu ML, Wang HP.

Medicine (Baltimore). 2018 Sep;97(38):e12101. doi: 10.1097/MD.0000000000012101.

15.

Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.

Vuijk FA, Hilling DE, Mieog JSD, Vahrmeijer AL.

J Surg Oncol. 2018 Aug;118(2):315-323. doi: 10.1002/jso.25139. Epub 2018 Sep 14. Review.

16.

Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.

Li T, Liu T, Wang M, Zhang M.

Medicine (Baltimore). 2018 Sep;97(37):e12359. doi: 10.1097/MD.0000000000012359.

17.

Gastric adenocarcinoma of fundic gland mucosa type localized in the submucosa: A case report.

Uchida A, Ozawa M, Ueda Y, Murai Y, Nishimura Y, Ishimatsu H, Okouchi Y, Ishiguro K, Hamada Y, Sasamoto R, Watanabe M, Sano N, Miyamoto R, Inagawa S, Kikuchi K.

Medicine (Baltimore). 2018 Sep;97(37):e12341. doi: 10.1097/MD.0000000000012341.

18.
19.

Acetylcholine induces stem cell properties of gastric cancer cells of diffuse type.

Nguyen PH, Touchefeu Y, Durand T, Aubert P, Duchalais E, Bruley des Varannes S, Varon C, Neunlist M, Matysiak-Budnik T.

Tumour Biol. 2018 Sep;40(9):1010428318799028. doi: 10.1177/1010428318799028.

PMID:
30207200
20.

Effects of Post-Surgical Parenteral Nutrition on Patients with Gastric Cancer.

Jin Y, Yong C, Ren K, Li D, Yuan H.

Cell Physiol Biochem. 2018;49(4):1320-1328. doi: 10.1159/000493410. Epub 2018 Sep 11.

Supplemental Content

Loading ...
Support Center